H44.2A3
H44.2A3 — Degenerative myopia with choroidal neovascularization, bilateral
Billable / specific codeICD-10-CMbilateral
H44.2A3 is a billable, specific ICD-10-CM code for degenerative myopia with choroidal neovascularization, bilateral. It is valid for submission on a claim.
Risk adjustment
H44.2A3 does not map to an HCC and does not risk-adjust under CMS-HCC V28. That is normal — most ICD-10 codes do not. It still needs to be coded correctly; it just will not move a RAF score.
Medicare coverage
H44.2A3 is named in 16 Medicare coverage policies — 16 listing it as supporting medical necessity. Which of them applies to you depends on your Medicare contractor, and coverage genuinely differs by state.
- A52370Billing and Coding: Bevacizumab and biosimilars
- A52451Billing and Coding: Ranibizumab and biosimilars, Aflibercept, Aflibercept HD, Brolucizumab-dbll, Faricimab-svoa, PAVBLU™aflibercept-ayyh, AHZANTIVE®aflibercept-abzv. ENZEEVU™aflibercept-mrbb, OPUVIZ™aflibercept-yszy and YESAFILI™ aflibercept-jbvf
- A53008Billing and Coding: Intraocular Bevacizumab
- A53060Billing and Coding: Ophthalmology: Extended Ophthalmoscopy and Fundus Photography
Related codes at this level
Codes that share H44.2A. If H44.2A3 is not quite right, the correct code is usually one of these.
Questions about H44.2A3
- Is H44.2A3 a billable ICD-10-CM code?
- Yes. H44.2A3 is a billable, specific ICD-10-CM code and is valid for submission on a claim.
- Where does H44.2A3 sit in the tabular list?
- Diseases of the eye and adnexa (H00-H59), in the block Disorders of vitreous body and globe (H43-H44).